In the later stages of PD, alterations in cholinergic function occur in cortical regions, the amygdala, and the hippocampus, leading to cognitive decline and dementia, and like other dementias, these can be treated to some degree with cholinesterase inhibitors [28]. This evidence concerns the gene BCHE and Parkinson disease.